Samsara BioCapital’s Nkarta NKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.4M | Hold |
3,507,666
| – | – | 0.72% | 14 |
|
|
2025
Q4 | $6.49M | Sell |
3,507,666
-260,369
| -7% | -$520K | 0.67% | 17 |
|
|
2025
Q3 | $7.8M | Hold |
3,768,035
| – | – | 1.02% | 14 |
|
|
2025
Q2 | $6.25M | Hold |
3,768,035
| – | – | 1.28% | 14 |
|
|
2025
Q1 | $6.93M | Hold |
3,768,035
| – | – | 1.24% | 15 |
|
|
2024
Q4 | $9.38M | Hold |
3,768,035
| – | – | 1.29% | 14 |
|
|
2024
Q3 | $17M | Hold |
3,768,035
| – | – | 3.27% | 8 |
|
|
2024
Q2 | $22.3M | Hold |
3,768,035
| – | – | 4.66% | 7 |
|
|
2024
Q1 | $40.7M | Buy |
3,768,035
+900,000
| +31% | +$9.36M | 6.3% | 5 |
|
|
2023
Q4 | $18.9M | Hold |
2,868,035
| – | – | 2.94% | 8 |
|
|
2023
Q3 | $3.99M | Hold |
2,868,035
| – | – | 1.22% | 23 |
|
|
2023
Q2 | $6.28M | Hold |
2,868,035
| – | – | 1.1% | 18 |
|
|
2023
Q1 | $10.2M | Hold |
2,868,035
| – | – | 2.1% | 11 |
|
|
2022
Q4 | $17.2M | Hold |
2,868,035
| – | – | 3.7% | 8 |
|
|
2022
Q3 | $37.7M | Hold |
2,868,035
| – | – | 8.81% | 2 |
|
|
2022
Q2 | $35.3M | Buy |
2,868,035
+833,333
| +41% | +$10.9M | 9.45% | 2 |
|
|
2022
Q1 | $23.2M | Sell |
2,034,702
-1
| -0% | -$11 | 5.85% | 3 |
|
|
2021
Q4 | $31.2M | Hold |
2,034,703
| – | – | 6.22% | 4 |
|
|
2021
Q3 | $56.6M | Hold |
2,034,703
| – | – | 9.39% | 2 |
|
|
2021
Q2 | $64.5M | Hold |
2,034,703
| – | – | 8.48% | 2 |
|
|
2021
Q1 | $66.9M | Hold |
2,034,703
| – | – | 13.48% | 1 |
|
|
2020
Q4 | $125K | Hold |
2,034,703
| – | – | 12.58% | 2 |
|
|
2020
Q3 | $61.2M | Buy |
+2,034,703
| New | +$60M | 17.06% | 2 |
|
Other funds holding NKTX
RCM
NMC
SOCM
GP
MAM
VCM
